414 related articles for article (PubMed ID: 12019078)
21. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
[TBL] [Abstract][Full Text] [Related]
22. Overexpression and mutation as a genetic mechanism of fluconazole resistance in Candida albicans isolated from human immunodeficiency virus patients in Indonesia.
Rosana Y; Yasmon A; Lestari DC
J Med Microbiol; 2015 Sep; 64(9):1046-1052. PubMed ID: 26297039
[TBL] [Abstract][Full Text] [Related]
23. Phenotypic and genotypic evaluation of fluconazole resistance in vaginal Candida strains isolated from HIV-infected women from Brazil.
Ribeiro MA; Paula CR; John R; Perfect JR; Cox GM
Med Mycol; 2005 Nov; 43(7):647-50. PubMed ID: 16396250
[TBL] [Abstract][Full Text] [Related]
24. The Candida dubliniensis CdCDR1 gene is not essential for fluconazole resistance.
Moran G; Sullivan D; Morschhäuser J; Coleman D
Antimicrob Agents Chemother; 2002 Sep; 46(9):2829-41. PubMed ID: 12183235
[TBL] [Abstract][Full Text] [Related]
25. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA
Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783
[TBL] [Abstract][Full Text] [Related]
26. Application of real-time quantitative PCR to molecular analysis of Candida albicans strains exhibiting reduced susceptibility to azoles.
Chau AS; Mendrick CA; Sabatelli FJ; Loebenberg D; McNicholas PM
Antimicrob Agents Chemother; 2004 Jun; 48(6):2124-31. PubMed ID: 15155210
[TBL] [Abstract][Full Text] [Related]
27. Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERG11 mutations.
Xu Y; Chen L; Li C
J Antimicrob Chemother; 2008 Apr; 61(4):798-804. PubMed ID: 18218640
[TBL] [Abstract][Full Text] [Related]
28. Molecular mechanisms of azole resistance in Candida tropicalis isolates causing invasive candidiasis in China.
Fan X; Xiao M; Zhang D; Huang JJ; Wang H; Hou X; Zhang L; Kong F; Chen SC; Tong ZH; Xu YC
Clin Microbiol Infect; 2019 Jul; 25(7):885-891. PubMed ID: 30472420
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.
Sanguinetti M; Posteraro B; Fiori B; Ranno S; Torelli R; Fadda G
Antimicrob Agents Chemother; 2005 Feb; 49(2):668-79. PubMed ID: 15673750
[TBL] [Abstract][Full Text] [Related]
30. The role of Candida dubliniensis in oral candidiasis in human immunodeficiency virus-infected individuals.
Schorling SR; Kortinga HC; Froschb M; Mühlschlegel FA
Crit Rev Microbiol; 2000; 26(1):59-68. PubMed ID: 10782340
[TBL] [Abstract][Full Text] [Related]
31. Longitudinal genotyping of Candida dubliniensis isolates reveals strain maintenance, microevolution, and the emergence of itraconazole resistance.
Fleischhacker M; Pasligh J; Moran G; Ruhnke M
J Clin Microbiol; 2010 May; 48(5):1643-50. PubMed ID: 20200288
[TBL] [Abstract][Full Text] [Related]
32. Rapid, transient fluconazole resistance in Candida albicans is associated with increased mRNA levels of CDR.
Marr KA; Lyons CN; Rustad TR; Bowden RA; White TC
Antimicrob Agents Chemother; 1998 Oct; 42(10):2584-9. PubMed ID: 9756759
[TBL] [Abstract][Full Text] [Related]
33. MDR1 overexpression combined with ERG11 mutations induce high-level fluconazole resistance in Candida tropicalis clinical isolates.
Jin L; Cao Z; Wang Q; Wang Y; Wang X; Chen H; Wang H
BMC Infect Dis; 2018 Apr; 18(1):162. PubMed ID: 29631565
[TBL] [Abstract][Full Text] [Related]
34. Changes in susceptibility to posaconazole in clinical isolates of Candida albicans.
Li X; Brown N; Chau AS; López-Ribot JL; Ruesga MT; Quindos G; Mendrick CA; Hare RS; Loebenberg D; DiDomenico B; McNicholas PM
J Antimicrob Chemother; 2004 Jan; 53(1):74-80. PubMed ID: 14657086
[TBL] [Abstract][Full Text] [Related]
35. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Sanglard D; Coste AT
Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
[TBL] [Abstract][Full Text] [Related]
36. Detection and antifungal susceptibility testing of oral Candida dubliniensis from human immunodeficiency virus-infected patients.
Chunchanur SK; Nadgir SD; Halesh LH; Patil BS; Kausar Y; Chandrasekhar MR
Indian J Pathol Microbiol; 2009; 52(4):501-4. PubMed ID: 19805956
[TBL] [Abstract][Full Text] [Related]
37. MDR1-mediated drug resistance in Candida dubliniensis.
Wirsching S; Moran GP; Sullivan DJ; Coleman DC; Morschhäuser J
Antimicrob Agents Chemother; 2001 Dec; 45(12):3416-21. PubMed ID: 11709317
[TBL] [Abstract][Full Text] [Related]
38. Missense mutation in CgPDR1 regulator associated with azole-resistant Candida glabrata recovered from Thai oral candidiasis patients.
Tantivitayakul P; Lapirattanakul J; Kaypetch R; Muadcheingka T
J Glob Antimicrob Resist; 2019 Jun; 17():221-226. PubMed ID: 30658200
[TBL] [Abstract][Full Text] [Related]
39. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.
Nadagir SD; Chunchanur SK; Halesh LH; Yasmeen K; Chandrasekhar MR; Patil BS
Southeast Asian J Trop Med Public Health; 2008 May; 39(3):492-5. PubMed ID: 18564689
[TBL] [Abstract][Full Text] [Related]
40. Expression of Major Efflux Pumps in Fluconazole-Resistant Candida albicans.
Pourakbari B; Teymuri M; Mahmoudi S; Valian SK; Movahedi Z; Eshaghi H; Mamishi S
Infect Disord Drug Targets; 2017; 17(3):178-184. PubMed ID: 28558643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
